Halley E. Gilbert - 15 Jun 2022 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Halley E. Gilbert
Issuer symbol
CTMX
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:06:22 UTC
Previous filing
03 Jun 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 15 Jun 2022 Common Stock 25,000 $1.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2023 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.